OQROGet OQRO Pro
Insider trade

Precision Biosciences (DTIL)CFO sold ~$8.5K

John Alexander Kelly, CFO at Precision Biosciences, sold ~$8.5K of Precision Biosciences shares.

~$8.5K
Approx. value · 1,303 sh @ $6.49
77K
Holds after · shares reported
Traded
Nov 3, 2025
Filed
Nov 4, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 22, 2025InsiderDirector purchased ~$6.8K of DTIL shares in the open market
  2. Sep 26, 2025Insider · Their first buy on recordDirector purchased ~$13K of DTIL shares in the open market
  3. Nov 3, 2025 · this disclosureInsiderCFO sold ~$8.5K of DTIL shares in the open market

What came next

  1. Nov 3, 2025Company filing · Form 8-K · ResultsReported its results
  2. Nov 3, 2025Insider · 2 peopleInsiders: 2 sales (~$26K)
  3. Dec 15, 2025InsiderDirector purchased ~$6.9K of DTIL shares in the open market
  4. Dec 16, 2025Insider · 2 peopleInsiders: 2 purchases (~$27K)
  5. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
  6. Jan 21, 2026Insider · 3 peopleInsiders: 3 sales (~$138K)
  7. Jan 22, 2026InsiderCEO sold ~$145K of DTIL shares in the open market
  8. Feb 18, 2026Insider · 4 peopleInsiders: 4 sales (~$148K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Precision Biosciences

For Precision Biosciences, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DTIL page.

Other recent filings by John Alexander Kelly, Chief Financial Officer

The full history of John Alexander Kelly, Chief Financial Officer is on the profile page.

How this filing works

Other disclosures at Precision Biosciences

Everything OQRO holds on this company is on its DTIL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data